The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Immunomodulatory effects of Vitamin D in multiple sclerosis
Abstract
Although Vitamin D is best known as a modulator of calcium homeostasis, it also has immune modulating potential. A protective effect of Vitamin D on multiple sclerosis is supported by the reduced risk associated with sun exposure and use of Vitamin D supplements. Moreover, high circulating levels of Vitamin D have been associated with lower risk of multiple sclerosis. In this study, we measured 1,25 (OH)(2) Vitamin D and 25 (OH) Vitamin D levels in multiple sclerosis patients separated into different clinical subgroups according to disease status. In addition, direct effects of 1,25 (OH)(2) Vitamin D on ex vivo CD4+ T cells and myelin-peptide specific T cell lines were investigated to gain more insight into putative regulatory mechanisms in the disease pathogenesis. One hundred and thirty-two Hispanic patients with clinically definite multiple sclerosis were studied, 58 with relapsing remitting multiple sclerosis during remission, 34 during relapse and 40 primary progressive multiple sclerosis cases. Sixty healthy individuals matched with respect to place of residence, race/ethnicity, age and gender served as controls. Levels of 25(OH)D(3) and 1,25(OH)(2)D(3), measured by ELISA were significantly lower in relapsing-remitting patients than in controls. In addition, levels in patients suffering relapse were lower than during remissions. In contrast, primary progressive patients showed similar values to controls. Proliferation of both freshly isolated CD4+ T cells and MBP-specific T cells was significantly inhibited by 1,25(OH)(2)D(3). Moreover, activated Vitamin D enhanced the development of IL-10 producing cells, and reduced the number of IL-6 and IL-17 secreting cells. Notably, Vitamin D receptor expression was induced by 1,25(OH)(2)D(3) in both activated and resting cells. Interestingly, T cells were able to metabolize 25(OH)D(3) into biologically active 1,25(OH)(2)D(3), since T cells express alpha1-hydroxylase constitutively. Finally, 1,25(OH)(2)D(3) also increased the expression and biological activity of indoleamine 2,3-dioxygenase, mediating significant increase in the number of CD4+CD25+ T regulatory cells. Collectively, these data suggest that 1,25(OH)(2)D(3) plays an important role in T cell homeostasis during the course of multiple sclerosis, thus making correction of its deficiency may be useful during treatment of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study
Hyppönen, E., Läärä, E., Reunanen, A., Järvelin, M.-R., & Virtanen, S. M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06580-1 · Cited by 1,928
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,897
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Meisel, R., Zibert, A., Laryea, M., Göbel, U., Däubener, W., & Dilloo, D. (2004) · Blood · doi:10.1182/blood-2003-11-3909 · Cited by 1,646
Cited by
Vitamin D and the immune system
Aranow, C. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31821b8755 · Cited by 1,436
Vitamin D: modulator of the immune system
Baeke, F., Takiishi, T., Korf, H., Gysemans, C., & Mathieu, C. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.04.001 · Cited by 1,300
Vitamin D and multiple sclerosis
Ascherio, A., Munger, K. L., & Simon, K. C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70086-7 · Cited by 576
Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity
Kamen, D. L., & Tangpricha, V. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0590-9 · Cited by 560
Joshi, S., Pantalena, L.-C., Liu, X. K., Gaffen, S. L., Liu, H., Rohowsky-Kochan, C., Ichiyama, K., Yoshimura, A., Steinman, L., Christakos, S., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05020-11 · Cited by 458
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
Simpson, S., Taylor, B., Blizzard, L., Ponsonby, A., Pittas, F., Tremlett, H., Dwyer, T., Gies, P., & van der Mei, I. (2010) · Annals of Neurology · doi:10.1002/ana.22043 · Cited by 457
Host and Environmental Factors Influencing Individual Human Cytokine Responses
ter Horst, R., Jaeger, M., Smeekens, S. P., Oosting, M., Swertz, M. A., Li, Y., Kumar, V., Diavatopoulos, D. A., Jansen, A. F. M., Lemmers, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.018 · Cited by 453
Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential
Dankers, W., Colin, E. M., van Hamburg, J. P., & Lubberts, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00697 · Cited by 442
Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti‐Inflammatory
L Bishop, E., Ismailova, A., Dimeloe, S., Hewison, M., & White, J. H. (2021) · JBMR Plus · doi:10.1002/jbm4.10405 · Cited by 392
Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases
Fernandes de Abreu, D. A., Eyles, D., & Féron, F. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.023 · Cited by 375
The impact of the gut microbiome on extra-intestinal autoimmune diseases
Miyauchi, E., Shimokawa, C., Steimle, A., Desai, M. S., & Ohno, H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00727-y · Cited by 367
An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis
Garg, N., & Smith, T. W. (2015) · Brain and Behavior · doi:10.1002/brb3.362 · Cited by 348
Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis
Mowry, E. M., Krupp, L. B., Milazzo, M., Chabas, D., Strober, J. B., Belman, A. L., McDonald, J. C., Oksenberg, J. R., Bacchetti, P., & Waubant, E. (2010) · Annals of Neurology · doi:10.1002/ana.21972 · Cited by 329
The Vitamin D Receptor and T Cell Function
Kongsbak, M., Levring, T. B., Geisler, C., & von Essen, M. R. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00148 · Cited by 326
Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses
Farez, M. F., Mascanfroni, I. D., Méndez-Huergo, S. P., Yeste, A., Murugaiyan, G., Garo, L. P., Balbuena Aguirre, M. E., Patel, B., Ysrraelit, M. C., Zhu, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.025 · Cited by 318
The Implication of Vitamin D and Autoimmunity: a Comprehensive Review
Yang, C.-Y., Leung, P. S. C., Adamopoulos, I. E., & Gershwin, M. E. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8361-3 · Cited by 299
Antico, A., Tampoia, M., Tozzoli, R., & Bizzaro, N. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.07.007 · Cited by 297
Vitamin D in inflammatory diseases
Wöbke, T. K., Sorg, B. L., & Steinhilber, D. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00244 · Cited by 284
Role of Vitamin D Beyond the Skeletal Function: A Review of the Molecular and Clinical Studies
Umar, M., Sastry, K. S., & Chouchane, A. I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061618 · Cited by 283
Colin, E. M., Asmawidjaja, P. S., van Hamburg, J. P., Mus, A. M. C., van Driel, M., Hazes, J. M. W., van Leeuwen, J. P. T. M., & Lubberts, E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25043 · Cited by 270
Smolders, J., Thewissen, M., Peelen, E., Menheere, P., Cohen Tervaert, J. W., Damoiseaux, J., & Hupperts, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006635 · Cited by 270
Sodium intake is associated with increased disease activity in multiple sclerosis
Farez, M. F., Fiol, M. P., Gaitán, M. I., Quintana, F. J., & Correale, J. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307928 · Cited by 267
Self-citationVitamin D and multiple sclerosis: An update
Pierrot-Deseilligny, C., & Souberbielle, J.-C. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.03.014 · Cited by 265
Environmental factors and their timing in adult-onset multiple sclerosis
Handel, A. E., Giovannoni, G., Ebers, G. C., & Ramagopalan, S. V. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.1 · Cited by 263
Vitamin D as a neurosteroid affecting the developing and adult brain
Groves, N. J., McGrath, J. J., & Burne, T. H. J. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105557 · Cited by 256
Lim, C. K., Bilgin, A., Lovejoy, D. B., Tan, V., Bustamante, S., Taylor, B. V., Bessede, A., Brew, B. J., & Guillemin, G. J. (2017) · Scientific Reports · doi:10.1038/srep41473 · Cited by 255
Ota, K., Dambaeva, S., Han, A.-R., Beaman, K., Gilman-Sachs, A., & Kwak-Kim, J. (2014) · Human Reproduction · doi:10.1093/humrep/det424 · Cited by 212
Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid
Correale, J., & Farez, M. F. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.05.014 · Cited by 47
Self-citationDoes Nutrition Affect Endometriosis?
Helbig, M., Vesper, A.-S., Beyer, I., & Fehm, T. (2021) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1207-0557 · Cited by 43
Sharma, B., Dutt, V., Kaur, N., Mittal, A., & Dabur, R. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112720 · Cited by 34
Metadata
- Authors
- Correale, J., Ysrraelit, M. C., & Gaitan, M. I.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03-24
- Volume
- 132
- Issue
- 5
- Pages
- 1146-1160
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2034742236
- Cited by
- 538
- References
- 64
- FWCI
- 36.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.